PediatricsSchedule H Prescription Drug
Mefnact-250 DT
Mefenamic Acid 250mg
Statutory Prescription Notice (Schedule H / H1 Drug)
Administer after meals to avoid gastrointestinal discomfort.
Product Overview
Pediatric dispersible formulation for fever reduction and mild-to-moderate pediatric pain.
Technical & Regulatory Specifications
| Brand Name | Mefnact-250 DT |
|---|---|
| Generic / INN Name | Mefenamic Acid Dispersible Tablets |
| Active Composition | Mefenamic Acid 250mg |
| Dosage Strength | 250mg |
| Dosage Form | Dispersible Tablets |
| Packaging Presentation | Blister Strip |
| Therapeutic Category | Pediatrics |
| Drug Classification | Schedule H Prescription Drug |
| Marketed By | Habbatus Pharmaceuticals Pvt. Ltd. |
| Manufacturing Standard | Qualified Partner Facility (GMP Certified Facility) |
Professional Reference Notice
This product summary is prepared exclusively for the informational reference of registered medical practitioners, dental surgeons, and licensed pharmacists in India. Not for consumer self-medication.